by Annie De Groot | Feb 5, 2014 | Thinking Out Loud -Blog
Reducing Immunogenicity with DeFT Engineering EpiVax is highly trusted by drug developers at large and small biopharma world-wide. We have accurately predicted immunogenicity in humans (published) and a major portion of our success is derived from providing...
by Annie De Groot | Nov 26, 2013 | News
Beyond humanization and de-immunization: tolerization as a method for reducing the immunogenicity of biologics Expert Rev. Clin. Pharmacol. 6(6), 651–662 (2013) Abstract Immune responses to some monoclonal antibodies (mAbs) and biologic proteins interfere with their...